Li, X., Zhang, Z., Li, Y., Chen, L., Huang, Y., Su, L., . . . Zhao, B. Mutation of lysine-specific demethylase 5 is associated with enhanced tumor immunity and favorable outcomes in pan-cancer immune checkpoint blockade. BMC.
Chicago Style (17th ed.) CitationLi, Xiaofeng, et al. Mutation of Lysine-specific Demethylase 5 Is Associated with Enhanced Tumor Immunity and Favorable Outcomes in Pan-cancer Immune Checkpoint Blockade. BMC.
MLA (9th ed.) CitationLi, Xiaofeng, et al. Mutation of Lysine-specific Demethylase 5 Is Associated with Enhanced Tumor Immunity and Favorable Outcomes in Pan-cancer Immune Checkpoint Blockade. BMC.
Warning: These citations may not always be 100% accurate.